553-Thumbnail Image.png

The Doctor of Nursing Practice Final Projects collection contains the completed works of students from the DNP Program at Arizona State University's College of Nursing and Health Innovation. These projects are the culminating product of the curricula and demonstrate clinical scholarship.

Collaborating Institutions:
College of Nursing and Health Innovation
Displaying 1 - 2 of 2
Filtering by

Clear all filters

162162-Thumbnail Image.png

DNP Project Report: Alternative Treatment for Mood in PD

Description
Background: Around 40-50% of people with Parkinson’s disease will develop anxiety or depression, the number one factors affecting their quality of life. Cognitive behavioral therapy is the most well-established intervention for anxiety and depression in people with Parkinson’s disease. Purpose: The project addresses a southwestern Parkinson-specific community center’s need for…

Background: Around 40-50% of people with Parkinson’s disease will develop anxiety or depression, the number one factors affecting their quality of life. Cognitive behavioral therapy is the most well-established intervention for anxiety and depression in people with Parkinson’s disease. Purpose: The project addresses a southwestern Parkinson-specific community center’s need for mental health by incorporating a cognitive behavioral therapy-based mental health program, guided by the Cognitive Behavioral Model. Methods: Recruitment at the center took place during a virtual weekly meeting with inclusion criteria of a Parkinson’s disease diagnosis, 50 years or older, and English speaking. A four-week, virtual, nurse-led cognitive behavioral therapy-based mental health program was created to examine the effects on anxiety, depression, and quality of life in ten people with Parkinson’s disease. Pre-and post-intervention Geriatric Anxiety Inventory (Cronbach’s alpha, 0.91), Hamilton Depression Rating Scale (Cronbach’s alpha, 0.87), and Parkinson’s Disease Questionnaires (Cronbach’s alpha, 0.84) were used to assess anxiety, depression, and quality of life. Results: Using a Two-tailed paired samples t-Test, mean values and p-value were calculated with alpha value of 0.05, t(39) = -0.10, p = .922 for anxiety, Alpha value of 0.05, t(16)=3.69, p=0.002 for depression, Alpha value of 0.05, t(38)=5.07, p<0.001 for quality of life, and Alpha value of 0.05, t(5)=4.54, p=0.006 for emotional wellbeing. Conclusion: A cognitive behavioral therapy-based mental health program at a Parkinson-specific center has the potential to improve quality of life and decrease depression in people with Parkinson’s disease. Implications: Research with larger sample sizes, longer duration of therapy, and in-person format would be beneficial.
ContributorsKielbania, Meghan (Author) / De' Santiago, Stephanie (Thesis advisor) / Arizona State University. College of Nursing & Healthcare Innovation (Contributor)
Created2021-04-28
162172-Thumbnail Image.png

Benefits of Medically Assisted Treatment in Opioid Use Disorder

Description
Introduction: For 2019 in the U.S. opioid overdose deaths neared 50,000 people. Increasing the number of Medication Assisted Treatment (MAT) programs available for the population is important to address this crisis (NIDA, n.d.). Objective: To evaluate if MAT improves retention rates for those with opioid use disorder (OUD) for…

Introduction: For 2019 in the U.S. opioid overdose deaths neared 50,000 people. Increasing the number of Medication Assisted Treatment (MAT) programs available for the population is important to address this crisis (NIDA, n.d.). Objective: To evaluate if MAT improves retention rates for those with opioid use disorder (OUD) for one Arizona organization’s (AZOrg) seven treatment facilities. Methods: ASU IRB approval obtained, and de-identified data were abstracted from the electronic records of AZOrg, for a year, March 2020 to February 2021. The data included patient age, sex, date of admission, length of stay, substance abused, and if MAT (buprenorphine, naltrexone, Methadone) was prescribed. Intellectus statistical package was used for analysis. Results: Among 3261 patients with a mean age of 35.81(18-82) years, 1528 (46.85%) were admitted for OUD that included 371 (24.28%) females, 686 of whom (44.9%) received MAT. For those treated with MAT mean length of stay was 35.78 (SD 30.34) days compared to a mean of 27.46 (30.79) days for those without MAT treatment. This finding was significant, for all forms of MAT, based on a two-tailed Two-Tailed Independent Samples t-Test test, p<.001. Discussion/Conclusion: Increasing awareness about OUD and MAT is needed when providing care to patients with OUD. Providing organization-specific information regarding MAT benefits can enhance the adoption of this intervention and aid in the recovery of those being treated for OUD. This analysis did not include the possible confounding factors such as a history of incarceration, duration of OUD before admission, or structural differences of individual facilities.
ContributorsChevelwala, Turab (Author) / Moffett, Carol (Thesis advisor) / Arizona State University. College of Nursing & Healthcare Innovation (Contributor)
Created2021-04-29